Dana M. Davis

716 total citations
12 papers, 512 citations indexed

About

Dana M. Davis is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Dana M. Davis has authored 12 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Dana M. Davis's work include Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Dana M. Davis is often cited by papers focused on Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Dana M. Davis collaborates with scholars based in United States, Netherlands and Canada. Dana M. Davis's co-authors include Richard P. Tobin, Martin D. McCarter, Kimberly R. Jordan, William A. Robinson, René González, Karl D. Lewis, Virginia F. Borges, Kevin G. Hoff, William D. Shrader and A. Scott Hinman and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Dana M. Davis

12 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana M. Davis United States 8 273 227 145 120 89 12 512
Christin Dewitz Germany 8 194 0.7× 102 0.4× 366 2.5× 174 1.4× 146 1.6× 8 608
Robin Soper United Kingdom 6 306 1.1× 215 0.9× 98 0.7× 25 0.2× 74 0.8× 7 511
Paul M. Nguyen Australia 13 234 0.9× 172 0.8× 220 1.5× 63 0.5× 73 0.8× 15 511
Adele Preaudet Australia 10 169 0.6× 157 0.7× 215 1.5× 52 0.4× 70 0.8× 16 431
Chengxian Xu China 9 193 0.7× 107 0.5× 410 2.8× 291 2.4× 246 2.8× 13 677
Chenyu Zhang China 11 91 0.3× 80 0.4× 186 1.3× 174 1.4× 91 1.0× 34 411
Siyu Tan China 13 220 0.8× 154 0.7× 262 1.8× 55 0.5× 103 1.2× 29 548
Xuefei Li China 11 151 0.6× 208 0.9× 237 1.6× 152 1.3× 138 1.6× 23 518
Ambra Natalini Italy 7 187 0.7× 163 0.7× 106 0.7× 43 0.4× 66 0.7× 14 393
Chuanyong Zhang China 13 125 0.5× 156 0.7× 382 2.6× 49 0.4× 231 2.6× 25 630

Countries citing papers authored by Dana M. Davis

Since Specialization
Citations

This map shows the geographic impact of Dana M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana M. Davis more than expected).

Fields of papers citing papers by Dana M. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana M. Davis. The network helps show where Dana M. Davis may publish in the future.

Co-authorship network of co-authors of Dana M. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Dana M. Davis. A scholar is included among the top collaborators of Dana M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana M. Davis. Dana M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yamamoto, Tomomi M., Patricia Webb, Dana M. Davis, et al.. (2022). Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors. Molecular Cancer Therapeutics. 21(4). 647–657. 11 indexed citations
2.
Davis, Dana M., Robert J. Van Gulick, Robert J. Torphy, et al.. (2022). Circulating CD8 + mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patients. Clinical & Translational Immunology. 11(1). e1367–e1367. 15 indexed citations
3.
McCarter, Martin D., Richard P. Tobin, Dana M. Davis, et al.. (2021). Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma.. Journal of Clinical Oncology. 39(15_suppl). 9536–9536. 4 indexed citations
4.
Borgers, Jessica S.W., Richard P. Tobin, Joshua M. Smith, et al.. (2020). High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes. ImmunoHorizons. 4(2). 82–92. 7 indexed citations
5.
Tobin, Richard P., Kimberly R. Jordan, Dana M. Davis, et al.. (2019). IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients. Frontiers in Oncology. 9. 1223–1223. 99 indexed citations
6.
Hinman, A. Scott, Charles R. Holst, Joey C. Latham, et al.. (2018). Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase. PLoS ONE. 13(8). e0201369–e0201369. 149 indexed citations
7.
Tobin, Richard P., Kimberly R. Jordan, William A. Robinson, et al.. (2018). Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab. International Immunopharmacology. 63. 282–291. 155 indexed citations
8.
Tobin, Richard P., Kimberly R. Jordan, Dana M. Davis, & Martin D. McCarter. (2017). Effects of in vitro ATRA treatment on human MDSC expansion and function.. Journal of Clinical Oncology. 35(7_suppl). 125–125. 2 indexed citations
9.
Tobin, Richard P., Dana M. Davis, Kimberly R. Jordan, & Martin D. McCarter. (2017). The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients. Journal of Leukocyte Biology. 102(2). 381–391. 49 indexed citations
10.
Jia, Haiyan, et al.. (2001). Cysteine-Rich and Basic Domain HIV-1 Tat Peptides Inhibit Angiogenesis and Induce Endothelial Cell Apoptosis. Biochemical and Biophysical Research Communications. 284(1). 245–245. 5 indexed citations
12.
Rowden, Geoffrey, et al.. (1988). Identification of CD4+, 2H4 + (T8γ +) suppressor-inducer cells in normal human epidermis and superficial dermis. British Journal of Dermatology. 119(2). 147–154. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026